Under Section 503B, outsourcing facilities may not compound drugs that are essentially copies of one or more approved drug products, and they are prohibited from compounding using bulk drug substances unless the substance appears on FDA's 503B bulks list or the drug appears on FDA's drug shortagel at the time of compounding, distribution and dispensing
In H1 2025, a weight loss app developer announced that they had partnered with a pharmaceutical company to personalize GLP-1 treatment using health data
In many lawsuits, patients were hospitalized and required feeding tubes or surgical intervention
In total, AOD 9604 failed to show meaningful weight loss in six clinical trials
The researchers must perform a calculation for concentration, how long the compounds are stored and which solvents are compatible based on established procedures at the institute and the purpose of their experiment
they lack real-world evidence